Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

The revelations came in part from the top federal prosecutor in Manhattan, Danielle R. Sassoon, who resigned rather than heed ...

Since the dawn of warfare, commanders have looked for ways to increase the speed and range of their ability to find enemy ...